News | January 24, 2024
Aster DM Healthcare gets shareholders nod to separate the GCC business
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
Sirius JV will be owned 51% by Sirius and 49% by Adani
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
Subscribe To Our Newsletter & Stay Updated
